Madrigal raises $143.8M in follow-on

On Dec. 18, cardio-metabolic disease company Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) raised $143.8 million through the sale of 1.7 million shares at $83 in a follow-on underwritten by Goldman Sachs, Evercore ISI, JMP Securities, Roth Capital Partners and H.C. Wainwright. The number includes a 225,904 share overallotment exercised on Dec. 21...